(Q37387692)

English

Emerging treatments in acute lymphoblastic leukemia

scientific article published on February 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

title

Emerging treatments in acute lymphoblastic leukemia (English)

1 reference

stated in

Europe PubMed Central

20 August 2017

1 reference

Crazzolara R

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19200049

retrieved

20 August 2017

Bendall L

series ordinal

2

1 reference

stated in

Europe PubMed Central

20 August 2017

1 February 2009

1 reference

stated in

Europe PubMed Central

20 August 2017

Current Cancer Drug Targets

1 reference

stated in

Europe PubMed Central

20 August 2017

9

1 reference

stated in

Europe PubMed Central

20 August 2017

1

1 reference

stated in

Europe PubMed Central

20 August 2017

19-31

1 reference

stated in

Europe PubMed Central

20 August 2017

Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1124/MOL.105.016154

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.727

Identifiers

DOI

10.2174/156800909787314057

1 reference

stated in

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

PubMed ID

19200049

retrieved

20 August 2017

ResearchGate publication ID

23987545

0 references

(Q37387692)

Emerging treatments in acute lymphoblastic leukemia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)